These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8977319)

  • 41. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc gamma RII-mediated B cell suppression.
    Rudge EU; Cutler AJ; Pritchard NR; Smith KG
    J Exp Med; 2002 Apr; 195(8):1079-85. PubMed ID: 11956299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentially regulated expression and function of CD22 in activated B-1 and B-2 lymphocytes.
    Lajaunias F; Nitschke L; Moll T; Martinez-Soria E; Semac I; Chicheportiche Y; Parkhouse RM; Izui S
    J Immunol; 2002 Jun; 168(12):6078-83. PubMed ID: 12055217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogen alters thresholds for B cell apoptosis and activation.
    Grimaldi CM; Cleary J; Dagtas AS; Moussai D; Diamond B
    J Clin Invest; 2002 Jun; 109(12):1625-33. PubMed ID: 12070310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM.
    Stoddart A; Ray RJ; Paige CJ
    Int Immunol; 1997 Oct; 9(10):1571-9. PubMed ID: 9352363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies.
    O'Keefe TL; Williams GT; Batista FD; Neuberger MS
    J Exp Med; 1999 Apr; 189(8):1307-13. PubMed ID: 10209047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and function of CD22, a B-cell restricted molecule.
    Moyron-Quiroz JE; Partida-Sánchez S; Donís-Hernández R; Sandoval-Montes C; Santos-Argumedo L
    Scand J Immunol; 2002 Apr; 55(4):343-51. PubMed ID: 11967115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design and synthesis of a multivalent homing device for targeting to murine CD22.
    Sliedregt LA; van Rossenberg SM; Autar R; Valentijn AR; van der Marel GA; van Boom JH; Piperi C; van der Merwe PA; Kuiper J; van Berkel TJ; Biessen EA
    Bioorg Med Chem; 2001 Jan; 9(1):85-97. PubMed ID: 11197350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.
    Nitschke L; Floyd H; Ferguson DJ; Crocker PR
    J Exp Med; 1999 May; 189(9):1513-8. PubMed ID: 10224292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.
    Razi N; Varki A
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7469-74. PubMed ID: 9636173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD22 antigen: biosynthesis, glycosylation and surface expression of a B lymphocyte protein involved in B cell activation and adhesion.
    Schwartz-Albiez R; Dörken B; Monner DA; Moldenhauer G
    Int Immunol; 1991 Jul; 3(7):623-33. PubMed ID: 1716973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells.
    Roes J; Rajewsky K
    J Exp Med; 1993 Jan; 177(1):45-55. PubMed ID: 8418208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model.
    Wöhner M; Born S; Nitschke L
    Eur J Immunol; 2012 Nov; 42(11):3009-18. PubMed ID: 22965838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fc epsilon RI and CD22 mRNA are expressed in early B-lineage and myeloid leukemia cell lines.
    Toba K; Hanawa H; Sakaue M; Yoshida K; Itoh H; Tsuchiyama J; Maruyama S; Narita M; Takahashi M; Watanabe K; Aizawa Y
    Leuk Res; 2003 Feb; 27(2):173-82. PubMed ID: 12526923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Internalization of the lymphocytic surface protein CD22 is controlled by a novel membrane proximal cytoplasmic motif.
    Chan CH; Wang J; French RR; Glennie MJ
    J Biol Chem; 1998 Oct; 273(43):27809-15. PubMed ID: 9774390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2.
    Leung SO; Goldenberg DM; Dion AS; Pellegrini MC; Shevitz J; Shih LB; Hansen HJ
    Mol Immunol; 1995 Dec; 32(17-18):1413-27. PubMed ID: 8643111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
    Kozmik Z; Wang S; Dörfler P; Adams B; Busslinger M
    Mol Cell Biol; 1992 Jun; 12(6):2662-72. PubMed ID: 1375324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of the gene variations in human CD22.
    Hatta Y; Tsuchiya N; Matsushita M; Shiota M; Hagiwara K; Tokunaga K
    Immunogenetics; 1999 Apr; 49(4):280-6. PubMed ID: 10079291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms in the Cd22 gene of inbred mouse strains.
    Lajaunias F; Ibnou-Zekri N; Fossati Jimack L; Chicheportiche Y; Parkhouse RM; Mary C; Reininger L; Brighouse G; Izui S
    Immunogenetics; 1999 Oct; 49(11-12):991-5. PubMed ID: 10501843
    [No Abstract]   [Full Text] [Related]  

  • 59. CD22 binds to alpha-2,6-sialyltransferase-dependent epitopes on COS cells.
    Stamenkovic I; Sgroi D; Aruffo A
    Cell; 1992 Mar; 68(6):1003-4. PubMed ID: 1372195
    [No Abstract]   [Full Text] [Related]  

  • 60. Expression and structure of CD22 in acute leukemia.
    Boué DR; LeBien TW
    Blood; 1988 May; 71(5):1480-6. PubMed ID: 3258772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.